Irritable Bowel Syndrome

SEP 2, 2026 · JOURNAL ARTICLE

Metagenome-scale modeling to assess microbiome metabolic complementarity for precision microbiota transplantation therapies.

Gut Microbes

Mechanistic modeling study using computational predictions and limited empirical validation (murine model and observational human trial) to propose metabolic niche complementarity as a predictor of FMT outcomes; results are not yet confirmatory in clinical practice.

AUG 20, 2026 · JOURNAL ARTICLE

Long-term microbiome and clinical effects of a microbiome-guided personalized diet versus low-FODMAP diet in irritable bowel syndrome: A 12-month follow-up randomized controlled trial.

Gut Microbes

A 12-month follow-up RCT with blinded outcome assessment comparing two dietary interventions in IBS, showing sustained clinical benefit with personalized diet but requiring larger trials to confirm durability and microbiome mechanisms.